% Expired Patents = 40.0

Forward Citations = 91

Loading Chart...

6 inventors (with patents filed for the assignee):

Wasimul Haque (3 out of 26 patents)

Rajat Sethi (3 out of 12 patents)

Naranjan S Dhalla (2 out of 2 patents)

4. James L Charlton (1 out of 1 patent)

5. Krishnamurti Dakashinamurti (1 out of 1 patent)

6. Krishnamurti Dakshinamurti (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 7230009 - Pyridoxal analogues and methods of treatment (2007-06-12),

2. 6890943 - Pyridoxal analogues and methods of treatment (2005-05-10),

3. 6489345 - Treatment of diabetes and related pathologies (2002-12-03),

4. 6051587 - Treatment of iatrogenic and age-related hypertension and pharmaceutical (2000-04-18),

5. 6043259 - Treatment of cardiovascular and related pathologies (2000-03-28),

Company Overview

Medicure, Inc. is a pharmaceutical company dedicated to improving patient outcomes through the development of innovative cardiovascular and neurological medications. With a focus on research and clinical trials, Medicure is committed to delivering high-quality, effective treatments to patients worldwide. Through partnerships and collaborations, Medicure continues to play a key role in advancing healthcare and improving quality of life for individuals with various medical conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#37 in Winnipeg

#2,850 in Canada

Winnipeg, Canada

Medicure, Inc.

Forward Citations = 91

6 inventors:

Wasimul Haque (3 out of 26 patents)

Rajat Sethi (3 out of 12 patents)

Naranjan S Dhalla (2 out of 2 patents)

4. James L Charlton (1 out of 1 patent)

5. Krishnamurti Dakashinamurti (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Medicure, Inc.. Retrieved from https://idiyas.com/company/medicure

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]